# Matt Gamache-Asselin

> Matt Gamache-Asselin is a Series A investor backing Health Care. See 3 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 3
- Last investment: Jul 2024
- Lead investor: 0%
- Last updated: Aug 2026

Matt Gamache-Asselin is a Series A investor focused on Health Care and Personal Health. Matt Gamache-Asselin

## Contacts

5 contacts available for Matt Gamache-Asselin: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/matt-gamache-asselin?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Personal Health | 2 | 67% |
| Legal | 1 | 33% |
| Medical | 1 | 33% |
| Software | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Pre-Seed | 1 | 33% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Blue | Blue is an AI-powered EHR purpose-built for healthspan/longevity practices that gives doctors superhuman abilities, synced seamlessly with a personal health superapp for me and you.Imagine a healthcare system that actually takes care of your health *in advance* rather than fumbling to pick up the pieces after things go wrong.We'repassionate about a future in which far more diseases are prevented than treated, and it's effortless to improve your day-to-day quality of life, in both well-being and performance.Science >> Snake Oil |  | Pre-Seed | Jul 04, 2024 | https://joinblueai.com/ |
| Getlabs | Getlabs is the leading platform for at-home diagnostics.Healthcare organizations use Getlabs to send mobile phlebotomists to patients’ homes and collect labs, vitals, and advanced diagnostics. By leveraging Getlabs, partners can improve patient adherence and close gaps in care with same-day, nationwide availability.Our team has raised $50M fromstrategic investors including the two largest diagnostic laboratories in the United States, Labcorp and Quest. Getlabs’ mission is to save lives by expanding access to diagnostics for everyone. | $20M | Series A | Feb 03, 2022 | https://getlabs.com |
| Atrium LTS | Atrium builds products and services to help automate legal workflows, innovate new processes within law firms, and help firms identify and attract new clients. Its technology provides a better experience for legal clients than they previously thought possible, increasing communication and speed of service.The company collaborates withforward-thinking lawyers to help determine the direction and decisions for these products. | $10.5M | Series A | Jun 15, 2017 | https://www.atrium.co |

3 of 3 investments shown.

## Co-investors
- [Outlander Fund I Archimedes](https://shizune.co/investors/profile/arena-ventures) — VC Fund, 1 deal together
- [Argonautic Ventures](https://shizune.co/investors/profile/argonautic-ventures) — VC Fund, 1 deal together
- [Byers Capital](https://shizune.co/investors/profile/byers-capital) — VC Fund, 1 deal together
- [Caffeinated Capital](https://shizune.co/investors/profile/caffeinated-capital) — VC Fund, 1 deal together
- [Chang Corporation](https://shizune.co/investors/profile/chang-com-0014) — VC Fund, 1 deal together
- [CSC Upshot](https://shizune.co/investors/profile/csc-upshot) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund
- [The LegalTech Fund](https://shizune.co/investors/profile/the-legaltech-fund) — VC Fund
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Legal Angel Investors in United States](https://shizune.co/investors/legal-angel-investors-united-states)

## FAQ

### What does Matt Gamache-Asselin invest in?

Matt Gamache-Asselin invests primarily in Health Care, Personal Health and Legal startups, most often at Series A and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Matt Gamache-Asselin?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Matt Gamache-Asselin last invest?

The most recent investment recorded for Matt Gamache-Asselin closed in Jul 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co